ATR and neoplasm: Although DNA repair genes alterations and the resulting genomic instability have been explored in other tumor types, only few DDR inhibitors were employed as monotherapy or combined with chemotherapy in trials enrolling CRC patients, including PARP, WEE1, ATR, and CHK1 inhibitors.